Literature DB >> 2827921

Genetic restriction of cytolysis during equid herpesvirus 1 subtype 2 infection.

C G Bridges1, N Edington.   

Abstract

Six Welsh Mountain pony foals were experimentally infected with a subtype 2 isolate of Equid Herpesvirus 1 (EHV-1) and subsequently examined for T cell mediated cytotoxicity against both subtypes. Cytotoxicity was not observed at 3 or 7 days after primary exposure but virus-specific, and genetically restricted, cytotoxicity of EHV-1-labelled autologous skin fibroblasts could be demonstrated 7 and 21 days after the animals were given a second exposure to live virus. Killing of subtype 2 antigen-labelled targets was more efficient than subtype 1 coated cells. This finding was paralleled by the observation that virus-neutralizing and complement-fixing antibody levels were subtype specific after the primary infection but after secondary exposure were directed against both subtypes. During primary infection the lymphocyte proliferative response to EHV-1 subtype 2 was not evident at 7 days post infection (dpi) but by 18 dpi was present in all animals. The second exposure produced an earlier (3 dpi) and larger proliferative response which was specific to the infecting isolate. The non-specific proliferative response to Concanavalin A mitogen indicated that virus infection induced a state of activation in circulating lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827921      PMCID: PMC1542070     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Effect of age and pregnancy on the antibody and cell-mediated immune responses of horses to equine herpesvirus 1.

Authors:  J D Gerber; A E Marron; E P Bass; W H Beckenhauer
Journal:  Can J Comp Med       Date:  1977-10

Review 2.  Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections.

Authors:  G P Allen; J T Bryans
Journal:  Prog Vet Microbiol Immunol       Date:  1986

3.  Membrane phenotype of murine effector and suppressor T cells involved in delayed hypersensitivity and protective immunity to herpes simplex virus.

Authors:  A A Nash; P G Gell
Journal:  Cell Immunol       Date:  1983-02-01       Impact factor: 4.868

4.  HLA-restricted cytotoxic T lymphocyte and nonthymic cytotoxic lymphocyte responses to cytomegalovirus infection of bone marrow transplant recipients.

Authors:  G V Quinnan; N Kirmani; E Esber; R Saral; J F Manischewitz; J L Rogers; A H Rook; G W Santos; W H Burns
Journal:  J Immunol       Date:  1981-05       Impact factor: 5.422

Review 5.  Major histocompatibility complex restricted cell-mediated immunity.

Authors:  G M Shearer; A M Schmitt-Verhulst
Journal:  Adv Immunol       Date:  1977       Impact factor: 3.543

6.  Serological detection of equid herpesvirus 1 infections of the respiratory tract.

Authors:  G R Thomson; J A Mumford; J Campbell; L Griffiths; P Clapham
Journal:  Equine Vet J       Date:  1976-04       Impact factor: 2.888

7.  Tolerance and immunity in mice infected with herpes simplex virus: simultaneous induction of protective immunity and tolerance to delayed-type hypersensitivity.

Authors:  A A Nash; P G Gell; P Wildy
Journal:  Immunology       Date:  1981-05       Impact factor: 7.397

8.  Variation in cellular tropism between isolates of equine herpesvirus-1 in foals.

Authors:  J R Patel; N Edington; J A Mumford
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

9.  Lymphocyte responses to virus and mitogen in ponies during experimental infection with equine herpesvirus 1.

Authors:  S K Dutta; A Myrup; M K Bumgardner
Journal:  Am J Vet Res       Date:  1980-12       Impact factor: 1.156

10.  Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes.

Authors:  K K Sethi; Y Omata; K E Schneweis
Journal:  J Gen Virol       Date:  1983-02       Impact factor: 3.891

View more
  1 in total

1.  Equid herpesvirus 1 infection of endothelial cells requires activation of putative adhesion molecules: an in vitro model.

Authors:  D Smith; A Hamblin; N Edington
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.